The biosynthetic pathways of high energy sugar nucleotides are well known (Bülter and Elling, 1 1999; Cai, 2012) . Sugar nucleotides, except cytidine 5′-monophosphate N-acetylneuraminic acid 2 (CMP-Sialic Acid), such as UDP-Galactose, UDP-Glucose, GDP-mannose, and UDP-GlcNAc share 3 similar pathways described in the following (Bülter and Elling, 1999; Cai, 2012; Rexer et al., 2018; Yu 4 and Chen, 2016). The direct reaction of GDP and UDP, respectively, (sugar carriers) and 5 monosaccharides (sugar) is thermodynamically unfavorable (∆G>0) (Flamholz et al., 2011; Noor et al., 6 2014). Thus, to increase the energy level of monosaccharides, they are phosphorylated by ATP in a 7 kinase-catalyzed reaction. In the next step, a monosaccharide-1 phosphate guanyl-or uridyltransferase 8 is required to produce a high energy sugar nucleotide by the reaction of monosaccharide 1-phosphate 9 and UTP/GTP (Zhao et al., 2010) . UDP-GlcNAc is one of the sugar nucleotides that is in vivo produced 10 in the hexosamine pathway (Hanover et al., 2010) . It is the GlcNAc donor in the O-and N-11 glycosylation pathways and for O-GlcNAcylation (Hanover et al., 2010; Varki et al., 2017; Yang and 12 Qian, 2017). UDP-GlcNAc is also the first sugar nucleotide that is required in the assembly of lipid-13 linked oligosaccharides in the endoplasmic reticulum (ER) of eukaryotes (Aebi, 2013) . Moreover, in 14 order to in vitro build the core structure of monoclonal antibodies and other recombinant proteins, 15 UDP-GlcNAc is extensively needed (Sha et al., 2016) . 16 Chemical synthesis of UDP-GlcNAc in a five-step process has reached a yield of 15 % 17 (Heidlas et al., 1992) . Microbial fermentation has also not resulted in sufficient yields (Heidlas et al., 18 1992; Rodríguez-Díaz et al., 2012; Tabata et al., 2000; Ying et al., 2009) . Conversely, enzymatic 19 synthesis has shown much higher yields. UDP-GlcNAc with a maximum yield of 78 % (Shao et al., 2002) . In their study, AGX1 (the 1 mammalian type of GlmU) and GlmU were used together to increase the yield of GlcNAc-1-phosphate 2 to UDP-GlcNAc. The regeneration of ATP from ADP was conducted by pyruvate kinase using 3 phosphoenolpyruvate (Shao et al., 2002) . 4 In the study presented here, we used a novel set of recombinant enzymes -NahK, PmPpA as 5 well as Glucose-1-phosphate uridyltransferase (GalU), uridine monophosphate kinase (URA6) and 6 polyphosphate kinase (PPK3) -all produced in E. coli and purified using immobilized metal affinity 7 chromatography (IMAC) to synthesize UDP-GlcNAc (Figure 1 ). To add versatility to the cascade, 8 GalU was utilized to convert GlcNAc-1-phosphate to UDP-GlcNAc. The polyphosphate kinase PPK3 9 was used to convert diphosphate nucleotides into triphosphates with low-cost polyphosphate as a co-10 substrate (Nahálka and Pätoprstý, 2009 ). In addition, URA6 was used to produce UDP from UMP.
11
Diphosphate is known to inhibit GalU and, thus, PmPpA was used to catalyze the diphosphate 12 hydrolysis to increase the UDP-GlcNAc yield. To our knowledge, this study is the first which 13 demonstrates that UDP-GlcNAc can be produced with a yield approaching 100 % using a minimal 14 number of enzymes for the in situ regeneration of mono-, di-, and triphosphate nucleotides. The study 15 is complemented by a systematic investigation of the effect of temperature and co-factor concentration. 2. Material and methods 23 For a detailed list with chemicals and purification grades used see the supplementary 1 information. 2 2.1. Analytics: HPAEC -UV/CD 3 All measurements for quantification of analytes were carried out by high performance anion 4 exchange chromatography (HPAEC) with UV and conductivity detection (CD) (BioLCType DX320 -5 Idstein, Germany). The eluent gradient was adopted from the work of Ritter and co-workers and 6 optimized for our purpose (Ritter et al., 2006) . The optimized eluent gradient (5 -100 mM KOH) was 7 evaluated statistically ( Figure 2 ). For additional information on the HPAEC method and parameters see 8 the supplementary information. 
Pathway design 10
The engineered cell-free synthetic metabolic pathway consists of five enzymes (Figure 1 Netherlands) and the plasmid pET-28a(+) was purchased from Invitrogen (Carlsbad, USA). The gene 23 and corresponding protein sequences were obtained from the UniProt database: PmPpA (P57918), 24 NahK (E4R3E3), GalU (P0AEP3), PPK3 (Q5LSN8), and URA6 (O04905). Gene Designer 2.0 1 software (Gene Designer, DNA 2.0, Menlo Park, California) was used for optimizing the codon usage 2 of nucleotide sequences for expression in E. coli. The resulting sequences were synthesized de novo 3 and cloned by GeneArt™ (Thermo Fisher Scientific, Regensburg, Germany). The following restriction 4 sites for subcloning into vector pET-28a(+) were used: NcoI and XhoI for GalU, NahK and PmPpA 5 (enzymes carrying a C-terminal hexahistidin-tag (His-tag)), NdeI and XhoI with PPK3 and URA6 (for 6 an N-terminal His-tag). After transformation of the plasmids into E. coli, the DNA was isolated and the 7 accuracy of the constructs was checked by gene sequencing (Eurofins Genomics, Ebersberg, 8 Germany). al., 1989) . Aliquots of 150 µL were transferred to LB-agar plates to establish colonies for pre-12 cultures of 50 mL LB/TB-media in 100 mL shaker flasks. Pre-cultures were grown for 18 h at 37°C 13 and 180 rpm. Main cultures of 500 mL LB/TB-media in 2000 mL shaker flasks were then inoculated to 14 an OD 600 of 0.1 and grown at 37°C and 120 rpm. Induction was carried out by the addition of 1 mM 15 Isopropyl-β-D-thiogalactopyranosid (IPTG) to the culture when the OD 600 reached values of about 0.5.
16
All cultures were supplemented with 50 μg mL -1 kanamycin. Biomass was harvested at about 10 h after 17 induction (6 h for PmPpA harboring cells) by centrifugation at 10.000 x g for 15 min. Overexpression 18 was monitored by SDS-PAGE following a standard protocol (Laemmli, 1970) . Bio wet mass (BWM) 19 was stored at -20°C until purification. Media compositions are described in supplementary information 20 (Table SI 1 ).
21

Enzyme purification 22
For enzyme purification, immobilized metal affinity chromatography (IMAC) was used (ÄKTA 23 explorer 100, Amersham Bioscience plc, Uppsala, Sweden). 4 g (2 g PmPpA) of E. coli BWM were 24 suspended in 40 mL of equilibration buffer, containing 50 mM Tris/HCl, 300 mM NaCl and 5 mM 1 imidazole at pH 7.5. Cells were disintegrated with a high pressure homogenizer (Emulsiflex C5, 2 Avestin Inc., Ottawa, Canada) at 1000 bar. Cell debris was separated by centrifugation (45 min; 17.700 3 x g) and the supernatant was applied to an IMAC set-up equipped with an pre-equilibrated column 4 containing Ni 2+ -STREAMLINE chelating™ material (GE Healthcare, Freiburg, Germany) as a 5 stationary phase (column volume: 13 mL). After washing the column with equilibration buffer, elution 6 was carried out using a buffer containing 50 mM Tris/HCl, 300 mM NaCl and 500 mM imidazole at 7 pH 7.5. Fractions of 1 mL were collected. Protein concentration was determined according to Bradford 8 using bovine serum albumin as a standard (Bradford, 1976) . After addition of glycerol to a final 9 concentration of 50 %, enzyme stock solutions were stored at -20°C. For the rational design of an enzymatic pathway metabolic control analysis (MCA) can be 19 applied (Stephanopoulos et al., 1998) . MCA is based on the concept of sensitivity analysis allowing the 20 quantification of a perturbation (e.g., changes in enzyme concentrations) on metabolic system 21 properties, e.g. flux (see (Heinrich and Schuster, 1996) ) for a detailed theoretical description). Flux In Equation 2, 0 is the response coefficient of substrate I; J and J 0 is the flux at non-reference and 7 reference state, respectively. and 0 denote the concentration of substrate at non-reference and 8 reference state, respectively. where i is unity.
14 Design equations allow a fast identification of key control points (substrate and enzyme concentrations) 15 in the system where small changes may lead to large increases in certain (product) fluxes.
16
In this work, the concentration of substrates remained constant. Therefore, it was not required to 17 calculate response coefficients, and the design equation reduces to:
18
Equation 4
For the whole pathway it reads:
Equation 5
Based on Equation 5, sets of different experiments were conducted to calculate the FCCs based on 2 multiple linear regressions. Table I . 
Multienzyme reactions for the synthesis of UDP-GlcNAc
17
To verify the reproducible synthesis of UDP-GlcNAc by the multienzyme cascade, a one-pot 18 reaction containing all five enzymes (0.1 mg mL -1 Nahk, URA6, PPK3, GalU; 0.03 mg mL -1 PmPpa) at 19 conditions specified in M&M was carried out in biological triplicates and compared against a set of 20 negative control experiments (see supplementary information Table SI 2), where one enzyme each was 21 missing with the exception of PmPpa. The enzyme concentrations are constrained by the enzyme stock 1 solutions (see Table I ). Initial enzyme and substrate concentrations were selected empirically and based 2 on our findings can be optimized in future. In the positive controls, UDP-GlcNAc was detected after 3 about 10 min ( Figure 4 ). The concentration of UDP-GlcNAc after 120 min was about 750 µM, and 4 concentration time series for all metabolites showed good reproducibility (Figure 4 ).
5
In the following, the effects of temperature and co-factor concentration are investigated. Moreover, 6 using mathematically approaches, the enzyme kinetics are studied and a steady state design equation is To gain insight into the temperature dependency of the complete pathway, experiments were 5 carried out at four different temperatures (20, 30, 40, and 50°C) . The effect of temperature on the pH 6 value of Tris/HCl at pH 7.5 was negligible (data not shown). 
Equation 6
In Equation 6, J is the flux of UDP-GlcNAc (µM h -1 ); the pre-exponential constant A is 9.178 x 10 14
13
(µM h -1 ); R, is the universal gas constant (8.314 J K -1 mol -1 ); T is the temperature (K), and the 14 activation energy E a is 71.186 (kJ mol -1 ). A similar increase in volumetric productivity through 15 increasing the temperature has been observed in other multienzymatic reactions as well (Eixelsberger 16 and Nidetzky, 2014). Moreover, the multienzyme cascade experiment at 40°C showed that UDP-
17
GlcNAc yields approaching 100 % (after 70 min at 40°C) are feasible ( Figure 5A ). and Kitaoka, 2007) . The presence of magnesium ion is also necessary for the catalytic activity of GalU 23 from E. coli (Turnquist and Hansen, 1973 The role of divalent magnesium ions as a co-factor can be classified into two general categories: 5 magnesium-substrate complex formation and subsequent binding and turnover and magnesium-enzyme 6 complex formation (Cowan, 2002) . In the second case Mg 2+ either alters the enzyme structure and/or is 7 directly involved in the catalysis (Cowan, 2002) . In a study on uridine phosphates it was found that concentrations of 20, 45, 100 and 150 mM ( Figure 6A ). In the second set of experiments, the 14 productivity was investigated at 40°C with Mg +2 concentrations of 10, 15, 20 and 45 mM ( Figure 6B ).
15
The results indicate that the optimal co-factor concentration is temperature-dependent. It is equal or 16 below 20 mM at 30°C, and equal or above 45 mM at 40°C. To systematically analyze the kinetics and the impact of enzyme concentration on the UDP-
23
GlcNAc synthesis rate seven independent experiments were conducted in which one enzyme 24 concentration was changed at a time ( is much higher than the activity of GalUunpublished data). The mechanism of PolyP 14 consumption 23 processive or non-processiveis not known. However, it can be assumed that an excessive amount 24 of phosphate for the phosphorylation reactions is present. The kinetic parameters were estimated taking 1 all seven experiments (one fit) into account. Results of the parameter estimation are shown in Table IV . However, for the first minutes of the reaction the model fails to reflect the dynamics of the ADP/ATP 5 conversion ( Figure 4 ). This implies that the regeneration from polyphosphate by PPK3 using ATP, and 6 probably also UTP, follows a more complex reaction mechanism. Moreover, according to the model 7 there is no indication of any inhibition and, thus, under the conditions tested the network will always 8 result in a yield of 100% of UDP-GlcNAc.
9
Cross validation and discussion 10 It has been suggested that the best way to check the predictability of a model is to compare 11 additional independent experiments performed with simulated results (Broadhurst and Kell, 2006) .
12
Therefore, two experiments were carried out with various enzyme concentrations within the previously 13 investigated range of concentrations (denoted "CV_1" and "CV_2"; Table II ). The design equation 14 (Equation 5) was used to predict the UDP-GlcNAc flux for both reactions ( Figure 8A ). In addition, the 15 concentration over time of UDP-GlcNAc was simulated by the kinetic model ( Figure 8B ).
16
Regardless of the reference state, the design equation could predict the flux with a very good 17 accuracy (deviation between experimental and simulated flux < 1 %) for CV_2 and fairly well for 18 CV_1 (deviation of 11 %) ( Figure 8A and Figure SI 1) .
19
The kinetic model can simulate the concentration over time for CV_1 and CV_2 well.
20
Differences in UDP-GlcNAc concentrations between experimental and simulated data after 90 min are 21 less than 10 % for CV_1 and CV_2 ( Figure 8B ).
22
In conclusion, the models perform equally well in predicting the synthesis of UDP-GlcNAc 23 within the range of conditions investigated. The advantage of design equations is that it predicts the 24 flux by means of dimensionless parameters and, thus, has potential to be used in scale up studies, e.g. 
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Analytics: HPAEC-UV/CD
The AG11 (50 x 2mm) column was applied as a guard column, followed by two in-series analytical columns AS11 (250 x 2 mm). All separations were performed at 25°C. All samples and standards were injected three times with a volume of 12.5 µL. Eluent flow was 0.35 mL min -1 . All columns, components, and the software were purchased from Thermo Scientific (Darmstadt, Germany). Data logging and chromatogram analysis was performed with Chromeleon 6.60 software. The statistical evaluation of the quantification of metabolite concentrations by linear regression is shown in Appendix A.
Multienzymatic experiments for kinetic analysis
The experiments were conducted in 1.5 mL vials (Eppendorf AG, Hamburg, Germany) rotated at 300 rpm in a thermomixer (Eppendorf AG, Hamburg, Germany). Reactions were started by addition of GlcNAc, UMP, ATP (1 mM) to pre-mixed reaction volumes containing enzymes, buffer, co-factor and PolyP14 (2 mM) (PmPpA is not able to hydrolyse PolyP14unpublished data). To obtain reaction time series, 100 µL of samples were aliquoted and diluted in 700 µL of MilliQ water, preheated to 90°C, followed by another 10 min of heating at 90°C.
The quenching protocol was individually tested on each enzyme (except PmPpA) to ensure enzyme inactivation. Heating did not have significant effects on the concentration of the compounds (data not shown).
Results
Negative control experiments
In each reaction of negative control experiments, one enzyme of the cascade was not included in the reaction mixture. The concentration of UDP-GlcNAc was monitored over 120 minutes. None of negative control sets showed production of UDP-GlcNAc (see Table SI 2). Table III ). Error bars are the standard error of regression. For the simulated values the standard error of linear regression was taken into account.
Appendix A Method validation of the HPAEC-UV/CD measurement for the quantification of metabolites
The validation was carried out according to Gottwald (Gottwald, 2000) . Standard samples containing all metabolites were prepared in concentrations ranging from 5 to 170 µM for method validation and as internal standards for kinetic measurements. For the method validation lower (5 µM) and upper limits (170 µM) were measured at least 6 times and all other concentrations, with some exceptions, 3 times with the established gradient. GlcNAc-1P was measured by conductivityall other metabolites by UV detection. For each kinetic measurements, internal calibration standards were used.
Test for linearity-Mandel test
The mandel test was applied to test for linearity (Gottwald, 2000 ) (Mandel, 1964 . The results are shown in Table SI A I. UV/CD signals are linear over the range of concentrations (5 to 170 µMexcept UDP-GlcNAc (130 µM)) investigated for all metabolites (see Table SI A I). This is as the test statistic for each metabolite is smaller than the corresponding f-value. Test for homgeneity of variances Variances were tested for homogeneity to decide on whether a linear or a weighed linear regression applies. While for most metabolites variances determined from standard samples were inhomogeneous, there was no significant difference between linear and weighed linear regression for the calculation of concentration. Thus, we used linear regressions for the calculation of metabolite concentrations. 
